Triumvira Immunologics nabs $55m Series A
Austin, Texas-based Triumvira Immunologics Inc, a biopharmaceutical company, has raised $55 million in Series A financing.
Austin, Texas-based Triumvira Immunologics Inc, a biopharmaceutical company, has raised $55 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination